<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>25151429</identifier>
<setSpec>1579-2021</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cano Megías, Marta</dc:author>
<dc:author>González Albarrán, Olga</dc:author>
<dc:description xml:lang="en">Cystic fibrosis is the most common fatal inherited autosomal recessive disease in Caucasians, affecting approximately one out of every 2,000 births. Survival of patients with cystic fibrosis has significantly improved due to advances in respiratory and nutritional care, and their current average life expectancy is 30-40 years. Development of cystic fibrosis-related diabetes is a comorbidity that increases with age and may reach a prevalence up to 50% in adults. Its development is associated to impaired lung function and nutritional status, and early diagnosis and treatment are therefore essential to improve quality of life and performance status. Insulin therapy for diabetes and other early carbohydrate metabolism disorders may improve lung function and nutritional status of patients with cystic fibrosis.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Cystic fibrosis-related diabetes</dc:subject>
<dc:subject>Pulmonary function</dc:subject>
<dc:subject>Fibrosis quística</dc:subject>
<dc:subject>Cystic fibrosis</dc:subject>
<dc:subject>Función pulmonar</dc:subject>
<dc:subject>Diabetes relacionada con la fibrosis quística</dc:subject>
<dc:date>2015 Jan </dc:date>
<dc:title xml:lang="en">Cystic fibrosis-related diabetes: a distinct condition.</dc:title>
<dc:publisher>Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion</dc:publisher>
</metadata>
</record>
</pubmed-document>
